• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

意大利托斯卡纳地区 2016-2017 年侵袭性肺炎球菌病:整合多种数据源调查漏报情况。

Invasive Pneumococcal Disease in Tuscany Region, Italy, 2016-2017: Integrating Multiple Data Sources to Investigate Underreporting.

机构信息

Department of Translational Research and New Surgical and Medical Technologies, University of Pisa, 56126 Pisa, Italy.

Tuscany Regional Health Agency (Agenzia Regionale di Sanità della Toscana), 50141 Florence, Italy.

出版信息

Int J Environ Res Public Health. 2020 Oct 19;17(20):7581. doi: 10.3390/ijerph17207581.

DOI:10.3390/ijerph17207581
PMID:33086480
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7589942/
Abstract

Invasive pneumococcal disease (IPD) is a vaccine-preventable disease characterized by the presence of in normally sterile sites. Since 2007, Italy has implemented an IPD national surveillance system (IPD-NSS). This system suffers from high rates of underreporting. To estimate the level of underreporting of IPD in 2016-2017 in Tuscany (Italy), we integrated data from IPD-NSS and two other regional data sources, i.e., Tuscany regional microbiological surveillance (Microbiological Surveillance and Antibiotic Resistance in Tuscany, SMART) and hospitalization discharge records (HDRs). We collected (1) notifications to IPD-NSS, (2) SMART records positive for from normally sterile sites, and (3) hospitalization records with IPD-related International Classification of Diseases, Ninth Revision, Clinical Modification (ICD9) codes in discharge diagnoses. We performed data linkage of the three sources to obtain a combined surveillance system (CSS). Using the CSS, we calculated the completeness of the three sources and performed a three-source log-linear capture-recapture analysis to estimate total IPD underreporting. In total, 127 IPD cases were identified from IPD-NSS, 320 were identified from SMART, and 658 were identified from HDRs. After data linkage, a total of 904 unique cases were detected. The average yearly CSS notification rate was 12.1/100,000 inhabitants. Completeness was 14.0% for IPD-NSS, 35.4% for SMART, and 72.8% for HDRs. The capture-recapture analysis suggested a total estimate of 3419 cases of IPD (95% confidence interval (CI): 1364-5474), corresponding to an underreporting rate of 73.7% (95% CI: 34.0-83.6) for CSS. This study shows substantial underreporting in the Tuscany IPD surveillance system. Integration of available data sources may be a useful approach to complement notification-based surveillance and provide decision-makers with better information to plan effective control strategies against IPD.

摘要

侵袭性肺炎球菌病(IPD)是一种可通过疫苗预防的疾病,其特征是在正常无菌部位出现 。自 2007 年以来,意大利实施了一项侵袭性肺炎球菌病国家监测系统(IPD-NSS)。该系统存在高漏报率的问题。为了估计 2016-2017 年托斯卡纳(意大利)侵袭性肺炎球菌病的漏报水平,我们整合了 IPD-NSS 和另外两个区域数据源的数据,即托斯卡纳区域微生物监测(托斯卡纳微生物监测和抗生素耐药性,SMART)和住院记录(HDR)。我们收集了(1)向 IPD-NSS 的报告,(2)SMART 记录中来自正常无菌部位的 阳性结果,以及(3)在出院诊断中具有侵袭性肺炎球菌病相关国际疾病分类,第九修订版,临床修正(ICD9)编码的住院记录。我们对三个来源的数据进行了链接,以获得一个综合监测系统(CSS)。使用 CSS,我们计算了三个来源的完整性,并进行了三源对数线性捕获-再捕获分析,以估计总 IPD 漏报率。总共从 IPD-NSS 中确定了 127 例 IPD 病例,从 SMART 中确定了 320 例,从 HDR 中确定了 658 例。数据链接后,共发现 904 例独特病例。平均每年 CSS 报告率为 12.1/100,000 居民。IPD-NSS 的完整性为 14.0%,SMART 为 35.4%,HDR 为 72.8%。捕获-再捕获分析表明,总共有 3419 例 IPD 病例(95%置信区间(CI):1364-5474),这对应于 CSS 的总漏报率为 73.7%(95% CI:34.0-83.6)。这项研究表明,托斯卡纳侵袭性肺炎球菌病监测系统存在大量漏报。整合现有数据源可能是一种有用的方法,可以补充基于报告的监测,并为决策者提供更好的信息,以制定有效的侵袭性肺炎球菌病控制策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3a1/7589942/816742f98219/ijerph-17-07581-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3a1/7589942/6e3b1e737e41/ijerph-17-07581-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3a1/7589942/816742f98219/ijerph-17-07581-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3a1/7589942/6e3b1e737e41/ijerph-17-07581-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3a1/7589942/816742f98219/ijerph-17-07581-g002.jpg

相似文献

1
Invasive Pneumococcal Disease in Tuscany Region, Italy, 2016-2017: Integrating Multiple Data Sources to Investigate Underreporting.意大利托斯卡纳地区 2016-2017 年侵袭性肺炎球菌病:整合多种数据源调查漏报情况。
Int J Environ Res Public Health. 2020 Oct 19;17(20):7581. doi: 10.3390/ijerph17207581.
2
A surveillance system of Invasive Pneumococcal Disease in North-Eastern Italy.意大利东北部侵袭性肺炎球菌疾病监测系统。
Ann Ig. 2016 Jan-Feb;28(1):15-24. doi: 10.7416/ai.2016.2081.
3
A retrospective analysis of hospital discharge records for S. pneumoniae diseases in the elderly population of Florence, Italy, 2010-2012.对2010 - 2012年意大利佛罗伦萨老年人群肺炎链球菌疾病的医院出院记录进行回顾性分析。
Hum Vaccin Immunother. 2015;11(1):156-65. doi: 10.4161/hv.34418. Epub 2014 Nov 1.
4
Vaccine preventable invasive bacterial diseases in Italy: A comparison between the national surveillance system and recorded hospitalizations, 2007-2016.意大利可通过疫苗预防的侵袭性细菌性疾病:2007-2016 年全国监测系统与记录住院病例的比较。
Vaccine. 2019 Jan 3;37(1):41-48. doi: 10.1016/j.vaccine.2018.11.047. Epub 2018 Nov 23.
5
Impact of pneumococcal conjugate vaccine (PCV7 and PCV13) on pneumococcal invasive diseases in Italian children and insight into evolution of pneumococcal population structure.肺炎球菌结合疫苗(PCV7和PCV13)对意大利儿童肺炎球菌侵袭性疾病的影响以及对肺炎球菌种群结构演变的洞察
Vaccine. 2017 Aug 16;35(35 Pt B):4587-4593. doi: 10.1016/j.vaccine.2017.07.010. Epub 2017 Jul 14.
6
Recurrent invasive pneumococcal disease in children--host factors and vaccination response.儿童复发性侵袭性肺炎球菌疾病——宿主因素及疫苗接种反应
Dan Med J. 2015 Jul;62(7).
7
Four years of universal pneumococcal conjugate infant vaccination in Germany: impact on incidence of invasive pneumococcal disease and serotype distribution in children.德国开展四年的通用型肺炎球菌结合疫苗儿童免疫接种:对侵袭性肺炎球菌病发病率和儿童血清型分布的影响。
Vaccine. 2012 Aug 31;30(40):5880-5. doi: 10.1016/j.vaccine.2012.06.068. Epub 2012 Jul 4.
8
Impact of vaccination on invasive pneumococcal disease in Italy 2007-2017: surveillance challenges and epidemiological changes.2007-2017 年意大利疫苗接种对侵袭性肺炎球菌病的影响:监测挑战和流行病学变化。
Epidemiol Infect. 2020 May 18;148:e187. doi: 10.1017/S0950268820001077.
9
Surveillance for invasive pneumococcal disease during 2000-2005 in a population of children who received 7-valent pneumococcal conjugate vaccine.对2000年至2005年期间接种7价肺炎球菌结合疫苗的儿童群体进行侵袭性肺炎球菌疾病监测。
Pediatr Infect Dis J. 2007 Sep;26(9):771-7. doi: 10.1097/INF.0b013e318124a494.
10
Incidence of invasive pneumococcal disease among individuals with sickle cell disease before and after the introduction of the pneumococcal conjugate vaccine.在引入肺炎球菌结合疫苗前后,镰状细胞病患者侵袭性肺炎球菌疾病的发病率。
Clin Infect Dis. 2007 Jun 1;44(11):1428-33. doi: 10.1086/516781. Epub 2007 Apr 18.

引用本文的文献

1
[The new 15-valent pneumococcal conjugate vaccine for the prevention of infections in pediatric age: a Health Technology Assessment].[用于预防儿童期感染的新型15价肺炎球菌结合疫苗:一项卫生技术评估]
J Prev Med Hyg. 2023 Jun 29;64(1 Suppl 1):E1-E160. doi: 10.15167/2421-4248/jpmh2023.64.1s1. eCollection 2023 Mar.
2
Manifesto on the Value of Adult Immunization: "We Know, We Intend, We Advocate".《成人免疫接种价值宣言》:“我们知晓,我们意愿,我们倡导”
Vaccines (Basel). 2021 Oct 22;9(11):1232. doi: 10.3390/vaccines9111232.
3
Pneumococcal and Influenza Vaccination Rates and Pneumococcal Invasive Disease Rates Set Geographical and Ethnic Population Susceptibility to Serious COVID-19 Cases and Deaths.

本文引用的文献

1
Impact of vaccination on invasive pneumococcal disease in Italy 2007-2017: surveillance challenges and epidemiological changes.2007-2017 年意大利疫苗接种对侵袭性肺炎球菌病的影响:监测挑战和流行病学变化。
Epidemiol Infect. 2020 May 18;148:e187. doi: 10.1017/S0950268820001077.
2
Vaccine preventable invasive bacterial diseases in Italy: A comparison between the national surveillance system and recorded hospitalizations, 2007-2016.意大利可通过疫苗预防的侵袭性细菌性疾病:2007-2016 年全国监测系统与记录住院病例的比较。
Vaccine. 2019 Jan 3;37(1):41-48. doi: 10.1016/j.vaccine.2018.11.047. Epub 2018 Nov 23.
3
The changing epidemiology of pneumococcal diseases.
肺炎球菌和流感疫苗接种率以及肺炎球菌侵袭性疾病发病率决定了不同地理区域和种族人群对严重 COVID-19 病例和死亡的易感性。
Vaccines (Basel). 2021 May 8;9(5):474. doi: 10.3390/vaccines9050474.
4
Impact of vaccination on invasive pneumococcal disease in Italy 2007-2017: surveillance challenges and epidemiological changes.2007-2017 年意大利疫苗接种对侵袭性肺炎球菌病的影响:监测挑战和流行病学变化。
Epidemiol Infect. 2020 May 18;148:e187. doi: 10.1017/S0950268820001077.
肺炎球菌疾病不断变化的流行病学。
Lancet Infect Dis. 2018 Sep;18(9):929-930. doi: 10.1016/S1473-3099(18)30399-2. Epub 2018 Jul 23.
4
Switch in a childhood pneumococcal vaccination programme from PCV13 to PCV10: a defendable approach?将儿童肺炎球菌疫苗接种计划中的13价肺炎球菌结合疫苗(PCV13)更换为10价肺炎球菌结合疫苗(PCV10):一种合理的方法?
Lancet Infect Dis. 2018 Aug;18(8):830-831. doi: 10.1016/S1473-3099(18)30346-3. Epub 2018 Jul 11.
5
Interpretation of the switch in a childhood pneumococcal vaccination programme from PCV13 to PCV10 in Belgium.比利时儿童肺炎球菌疫苗接种计划从PCV13转换为PCV10的解读。
Lancet Infect Dis. 2018 Aug;18(8):831-832. doi: 10.1016/S1473-3099(18)30410-9. Epub 2018 Jul 11.
6
Streptococcus pneumoniae: transmission, colonization and invasion.肺炎链球菌:传播、定植与侵袭。
Nat Rev Microbiol. 2018 Jun;16(6):355-367. doi: 10.1038/s41579-018-0001-8.
7
Vaccine-preventable disease incidence of pneumococcal conjugate vaccine in the Finnish invasive pneumococcal disease vaccine trial.芬兰侵袭性肺炎球菌病疫苗试验中肺炎球菌结合疫苗可预防疾病的发病率。
Vaccine. 2018 Mar 27;36(14):1816-1822. doi: 10.1016/j.vaccine.2018.02.088.
8
[The interplay of diagnostic and antimicrobial stewardship for the management of septic patients: the Tuscan model.].[脓毒症患者管理中诊断与抗菌药物管理的相互作用:托斯卡纳模式。]
Recenti Prog Med. 2018 Feb;109(2):133-136. doi: 10.1701/2865.28909.
9
Impact of pneumococcal conjugate vaccine (PCV7 and PCV13) on pneumococcal invasive diseases in Italian children and insight into evolution of pneumococcal population structure.肺炎球菌结合疫苗(PCV7和PCV13)对意大利儿童肺炎球菌侵袭性疾病的影响以及对肺炎球菌种群结构演变的洞察
Vaccine. 2017 Aug 16;35(35 Pt B):4587-4593. doi: 10.1016/j.vaccine.2017.07.010. Epub 2017 Jul 14.
10
Invasive meningococcal disease in the Veneto region of Italy: a capture-recapture analysis for assessing the effectiveness of an integrated surveillance system.意大利威尼托地区的侵袭性脑膜炎球菌病:一项用于评估综合监测系统有效性的捕获-再捕获分析
BMJ Open. 2017 May 2;7(4):e012478. doi: 10.1136/bmjopen-2016-012478.